An Interleukin-1 Signature in Breast Cancer Treated With Interleukin-1 Receptor Blockade: Implications for Treating Cytokine Release Syndrome of Checkpoint Inhibitors

Cancer Research - United States
doi 10.1158/0008-5472.can-18-2225
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)


Related search